MAC plc is a leading European contract research organization (CRO) specializing in clinical trials. Established in 1995, MAC operates a globally connected network of dedicated research sites across Europe and beyond. The company’s core business involves the design, execution, and management of clinical trials for pharmaceutical, biotechnology, and medical device companies. MAC’s primary service offering centers around providing comprehensive clinical trial support, encompassing site selection, patient recruitment, data management, regulatory submissions, and overall trial execution. The organization’s expertise spans a diverse range of therapeutic areas and clinical trial methodologies. MAC’s international presence is significant, with a dedicated team operating across multiple European countries. As a specialist CRO, MAC focuses on providing bespoke clinical trial solutions tailored to client needs. The company’s workforce includes highly skilled researchers, clinical professionals, and regulatory experts. MAC plc is classified as a limited company with SIC codes relating to specialized design activities and is currently operating as an active entity. The organization’s key focus is on accelerating drug development through efficient and compliant clinical trial processes. MAC plc’s staffing indicates a strong commitment to skilled workforce and international collaboration.

MAC plc is a leading European contract research organization (CRO) specializing in clinical trials. Established in 1995, MAC operates a globally connected network of dedicated research sites across Europe and beyond. The company’s core business involves the design, execution, and management of clinical trials for pharmaceutical, biotechnology, and medical device companies. MAC’s primary service offering centers around providing comprehensive clinical trial support, encompassing site selection, patient recruitment, data management, regulatory submissions, and overall trial execution. The organization’s expertise spans a diverse range of therapeutic areas and clinical trial methodologies. MAC’s international presence is significant, with a dedicated team operating across multiple European countries. As a specialist CRO, MAC focuses on providing bespoke clinical trial solutions tailored to client needs. The company’s workforce includes highly skilled researchers, clinical professionals, and regulatory experts. MAC plc is classified as a limited company with SIC codes relating to specialized design activities and is currently operating as an active entity. The organization’s key focus is on accelerating drug development through efficient and compliant clinical trial processes. MAC plc’s staffing indicates a strong commitment to skilled workforce and international collaboration.